TY - JOUR
T1 - P63 regulates glutaminase 2 expression
AU - Giacobbe, Arianna
AU - Bongiorno-Borbone, Lucilla
AU - Bernassola, Francesca
AU - Terrinoni, Alessandro
AU - Markert, Elke Katrin
AU - Levine, Arnold J.
AU - Feng, Zhaohui
AU - Agostini, Massimilano
AU - Zolla, Lello
AU - Agrò, Alessandro Finazzi
AU - Notterman, Daniel A.
AU - Melino, Gerry
AU - Peschiaroli, Angelo
N1 - Funding Information:
This work has been supported by the Medical Research Council, UK; grants from “Alleanza contro il Cancro” Grant (ACC12), MIUR/PRIN (20078P7T3K_001)/FIRB (RBIP06LCA9_0023, RBIP06LCA9_0C), AIRC grant (#5471), (2011-IG11955), Telethon Grant GGPO9133 to G.M., MIUR/PRIN 2008MRLSNZ_004, AIRC 5xmille (#9979), RF06 c.73, RF08 c.15, RF07 c.57 awarded to G.M., and the AIRC grant 9202 awarded to F.B.
PY - 2013/5/1
Y1 - 2013/5/1
N2 - The transcription factor p63 is critical for many biological processes, including development and maintenance of epidermal tissues and tumorigenesis. Here, we report that the TAp63 isoforms regulate cell metabolism through the induction of the mitochondrial glutaminase 2 (GLS2) gene both in primary cells and tumor cell lines. By ChIP analysis and luciferase assay, we confirmed that TAp63 binds directly to the p53/p63 consensus DNA binding sequence within the GLS2 promoter region. Given the critical role of p63 in epidermal differentiation, we have investigated the regulation of GLS2 expression during this process. GLS2 and TAp63 expression increases during the in vitro differentiation of primary human keratinocytes, and depletion of GLS2 inhibits skin differentiation both at molecular and cellular levels. We found that GLS2 and TAp63 expression are concomitantly induced in cancer cells exposed to oxidative stresses. siRNA-mediated depletion of GLS2 sensitizes cells to ROS-induced apoptosis, suggesting that the TAp63/GLS2 axis can be functionally important as a cellular antioxidant pathway in the absence of p53. Accordingly, we found that GLS2 is upregulated in colon adenocarcinoma. Altogether, our findings demonstrate that GLS2 is a bona fide TAp63 target gene, and that the TAp63-dependent regulation of GLS2 is important for both physiological and pathological processes.
AB - The transcription factor p63 is critical for many biological processes, including development and maintenance of epidermal tissues and tumorigenesis. Here, we report that the TAp63 isoforms regulate cell metabolism through the induction of the mitochondrial glutaminase 2 (GLS2) gene both in primary cells and tumor cell lines. By ChIP analysis and luciferase assay, we confirmed that TAp63 binds directly to the p53/p63 consensus DNA binding sequence within the GLS2 promoter region. Given the critical role of p63 in epidermal differentiation, we have investigated the regulation of GLS2 expression during this process. GLS2 and TAp63 expression increases during the in vitro differentiation of primary human keratinocytes, and depletion of GLS2 inhibits skin differentiation both at molecular and cellular levels. We found that GLS2 and TAp63 expression are concomitantly induced in cancer cells exposed to oxidative stresses. siRNA-mediated depletion of GLS2 sensitizes cells to ROS-induced apoptosis, suggesting that the TAp63/GLS2 axis can be functionally important as a cellular antioxidant pathway in the absence of p53. Accordingly, we found that GLS2 is upregulated in colon adenocarcinoma. Altogether, our findings demonstrate that GLS2 is a bona fide TAp63 target gene, and that the TAp63-dependent regulation of GLS2 is important for both physiological and pathological processes.
KW - Colon carcinoma
KW - Glutaminolysis
KW - P63
KW - Skin differentiation
UR - http://www.scopus.com/inward/record.url?scp=84877127022&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84877127022&partnerID=8YFLogxK
U2 - 10.4161/cc.24478
DO - 10.4161/cc.24478
M3 - Article
C2 - 23574722
AN - SCOPUS:84877127022
SN - 1538-4101
VL - 12
SP - 1395
EP - 1405
JO - Cell Cycle
JF - Cell Cycle
IS - 9
ER -